Showing results (2351-2360 of 2,888) with videos related to

Sort By:
Pageof 289
Journal of the National Comprehensive Cancer Network : JNCCN|November 2, 2016
Personalized Treatment for a Patient With a BRAF V600E Mutation Using Dabrafenib and a Tumor Treatment Fields Device in a High-Grade Glioma Arising From GangliogliomaSilviya K Meletath, Dean Pavlick, Tim Brennan, et al.
The Journal of Molecular Diagnostics : JMD|December 29, 2016
Next-Generation Assessment of Human Epidermal Growth Factor Receptor 2 (ERBB2) Amplification Status: Clinical Validation in the Context of a Hybrid Capture-Based, Comprehensive Solid Tumor Genomic Profiling AssayDara S Ross, Ahmet Zehir, Donavan T Cheng, et al.
Pediatric Blood & Cancer|January 19, 2017
Identification of NTRK fusions in pediatric mesenchymal tumorsDean Pavlick, Alexa B Schrock, Denise Malicki, et al.
Clinical Trials (London, England)|August 17, 2023
Assessing the use of observational methods and real-world data to emulate ongoing randomized controlled trialsJoshua D Wallach, Yihong Deng, Eric C Polley, et al.
Circulation|April 30, 2024
Atherosclerosis Is a Smooth Muscle Cell-Driven Tumor-Like DiseaseHuize Pan, Sebastian E Ho, Chenyi Xue, et al.
Archives of Gynecology and Obstetrics|August 15, 2021
Immunohistochemical analysis of glassy cell carcinoma of the cervix reveals robust lymphocyte infiltrate and the expression of targetable inhibitory immune checkpointsErin A Blake, Malcolm S Ross, Megan E Ross, et al.
JAMIA Open|January 12, 2023
Integrating real-world data to assess cardiac ablation device outcomes in a multicenter study using the OMOP common data model for regulatory decisions: implementation and evaluationYue Yu, Guoqian Jiang, Eric Brandt, et al.
JAMA Network Open|January 23, 2023
Comparative Effectiveness of Immune Checkpoint Inhibitors vs Chemotherapy in Patients With Metastatic Colorectal Cancer With Measures of Microsatellite Instability, Mismatch Repair, or Tumor Mutational BurdenJulia C F Quintanilha, Ryon P Graf, Virginia A Fisher, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 7, 2017
Identification of Targetable ALK Rearrangements in Pancreatic Ductal AdenocarcinomaAatur D Singhi, Siraj M Ali, Jill Lacy, et al.
The Oncologist|June 29, 2019
FGFR2-Altered Gastroesophageal Adenocarcinomas Are an Uncommon Clinicopathologic Entity with a Distinct Genomic LandscapeSamuel J Klempner, Russell Madison, Vivek Pujara, et al.
Pageof 289